Pitcairn Co. Sells 829 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pitcairn Co. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% during the fourth quarter, HoldingsChannel reports. The firm owned 15,938 shares of the healthcare conglomerate’s stock after selling 829 shares during the period. Pitcairn Co.’s holdings in UnitedHealth Group were worth $8,062,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Grant Private Wealth Management Inc bought a new stake in UnitedHealth Group during the fourth quarter worth about $673,000. Arete Wealth Advisors LLC boosted its stake in UnitedHealth Group by 33.6% in the fourth quarter. Arete Wealth Advisors LLC now owns 6,682 shares of the healthcare conglomerate’s stock worth $3,377,000 after buying an additional 1,681 shares in the last quarter. Motley Fool Asset Management LLC raised its stake in shares of UnitedHealth Group by 2.3% during the fourth quarter. Motley Fool Asset Management LLC now owns 42,546 shares of the healthcare conglomerate’s stock worth $21,522,000 after acquiring an additional 940 shares in the last quarter. World Investment Advisors grew its holdings in shares of UnitedHealth Group by 7.8% during the 4th quarter. World Investment Advisors now owns 44,800 shares of the healthcare conglomerate’s stock valued at $22,662,000 after purchasing an additional 3,225 shares during the last quarter. Finally, Disciplined Investors L.L.C. bought a new stake in UnitedHealth Group in the fourth quarter worth $684,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Oppenheimer raised their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Up 0.1 %

UNH stock opened at $523.61 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business has a fifty day moving average price of $509.15 and a 200-day moving average price of $542.83. The stock has a market capitalization of $478.95 billion, a P/E ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.